ArticleEuropean oral research2026
Influence of activation systems on the removal and apical extrusion of a bioceramic intracanal medicament in immature teeth: an in vitro study.
Article in European oral research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to evaluate the effects of passive ultrasonic irrigation (PUI) and sonic activation (SA) on apical extrusion and the removal efficacy of bioceramic (BC), and calcium hydroxide (CH) based intracanal materials in simulated open-apex teeth. Materials and Methods: Thirty-two extracted mandibular canines were prepared according to ISO #140, and an open-apex condition was created by apical resection. Specimens were randomly assigned to bioceramic (Bio-C Temp) and CH (DiaPaste) intracanal medication groups and subdivided among PUI or SA methods (n = 8). Extruded intracanal medicament was collected in pre-weighed tubes, and residual medicament was scored under a microscope. Residual intracanal medicament was evaluated using a four-grade scoring system. Normality was assessed using the Shapiro-Wilk test; group comparisons were performed with the Kruskal-Wallis test and Dunn's post-hoc test, with significance set at p<0.05. Results: Apical Extrusion values were as follows: Group BC-PUI = 0.048 mg, Group BC-SA = 0.036 mg, Group CH-PUI = 0.052 mg, and Group CH-SA = 0.049 mg. No significant difference was observed in apical extrusion among the groups (p = 0.265). Median residual scores were Group BC-PUI = 0.5, Group BC-SA = 3, Group CH-PUI = 0.5 and Group CH-SA = 1. PUI resulted in significantly lower residual medicament scores than SA (p = 0.002). Conclusion: Bio-C Temp demonstrated superior removal and apical extrusion characteristics were comparable to CH. These findings support its potential as a reliable alternative to CH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.